Today at the American Podiatric Medical Association’s 2005 Annual Scientific Meeting, our client, Xilas Medical, Inc. announced the availability of its Vibration Perception Threshold (VPT) Meter. The VPT Meter is a clinical-assessment instrument designed to help health care professionals evaluate peripheral sensory neuropathy of the lower extremities. Diabetic peripheral neuropathy, a nerve disorder, is believed to be caused by high blood glucose, and about 60 percent of the 18.2 million people with diabetes in the U.S. have some form of neuropathy.
Neuropathy causes a variety of symptoms in diabetic patients, including loss of sensation and numbness which may become progressively worse over time. When placed onto the bottom of a patient’s foot, the health care professional can regulate and increase the amount of vibration in the device until the patient feels it. The threshold is quantified with a numeric read-out. Diabetic patients with neuropathy are at high risk for foot ulceration and amputation due to their inability to feel pain in their feet as well as a reduced ability to heal. The VPT Meter is designed to detect neuropathy early so that health care professionals can intervene and prevent future problems from occurring.